Author

N. F. Mivechi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

L. Ko· 2 shared A. S. Arbab· 1 shared B. R. Achyut· 1 shared H. Zhang· 1 shared K. Angara· 1 shared M. L. Gupta· 1 shared V. J. Gurvich· 1 shared Z. Yang· 1 shared

Activity by Year

2019-2019 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 16 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

L. Ko

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Oncoprotein GT198 Vaccination Delays Tumor Growth in MMTV-PyMT Mice

B. R. Achyut, H. Zhang, K. Angara, N. F. Mivechi, A. S. Arbab, L. Ko

This study shows that vaccinating MMTV-PyMT mice with GT198 protein delays tumor growth and reduces metastasis, suggesting a shared tumorigenic pathway between human and mouse cancers.

bioRxiv · Jul 5, 2019Cancer Biology

Oncoprotein GT198 is a direct target of taxol

Z. Yang, V. J. Gurvich, M. L. Gupta, N. F. Mivechi, L. Ko

This study identifies GT198 as a direct target of taxol, showing it binds to GT198's DNA-binding domain and inhibits its function, which may explain taxol's efficacy and side effects in cancer treatment.

bioRxiv · Jun 19, 2019 · PreprintPharmacology & Toxicology